Precision AI Surgical Planning System (PAI-SPS)
Precision AI Pty, Ltd. · Decision date Jan 12, 2026
What did the FDA decide?
FDA records K251558 as a 510(k) premarket notification, with a decision dated Jan 12, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Jan 12, 2026
Regulatory record facts
- Identifier
- K251558
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Precision AI Pty, Ltd.
- Product code
- QHE
- Decision code
- SESE
- Decision date
- Jan 12, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Shoulder Arthroplasty Implantation System.
- Applicant
- Precision AI Pty, Ltd.
- Product code
- QHE
- FDA device class
- 2
FDA decision timeline
K251558 received
Application receipt date recorded by FDA.
K251558 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QHE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Materialise NV | 510(k) clearance | Jun 9, 2026 | FDA | |
Signature ONE SystemK261510 | Orthosoft Inc. (d/b/a) Zimmer CAS | 510(k) clearance | Jun 4, 2026 | FDA |
Signature ONE SystemK260104 | Orthosoft Inc. (d/b/a) Zimmer CAS | 510(k) clearance | Feb 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Precision AI Pty, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Fortitude Valley
Sources and methodology
- Original FDA record: K251558
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

